Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/16860852

Download in:

View as

General Info

PMID
16860852